Pivotal bioVenture Partners

Pivotal bioVenture Partners, established in 2016, is a San Francisco-based venture capital firm focusing on early-stage investments in biotechnology companies. With a $300 million fund, they invest in privately held North American and European companies developing innovative therapeutic products and platforms to address significant unmet medical needs. Their investment strategy spans from company creation through mid and late-stage clinical development. The firm's team, with diverse experience in venture capital, company building, and drug discovery and development, works closely with entrepreneurs to advance their businesses.